ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) stock closed at 16.94 per share at the end of the most recent trading day (a -2.48% change compared to the prior day closing price) with a volume of 704.33K shares and market capitalization of 2.72B. Is a component of Russell 1000 indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 580 people. ACADIA Pharmaceuticals Inc. CEO is Stephen R. Davis.

The one-year performance of ACADIA Pharmaceuticals Inc. stock is -55.94%, while year-to-date (YTD) performance is -68.31%. ACAD stock has a five-year performance of -51.57%. Its 52-week range is between 15.68 and 57.46, which gives ACAD stock a 52-week price range ratio of 3.02%

ACADIA Pharmaceuticals Inc. currently has a PE ratio of -10.10, a price-to-book (PB) ratio of 4.75, a price-to-sale (PS) ratio of 5.79, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -34.30%, a ROC of -40.38% and a ROE of -41.40%. The company’s profit margin is -56.25%, its EBITDA margin is -56.10%, and its revenue ttm is $463.36 Million , which makes it $2.88 revenue per share.

Of the last four earnings reports from ACADIA Pharmaceuticals Inc., there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.26 for the next earnings report. ACADIA Pharmaceuticals Inc.’s next earnings report date is 03rd Nov 2021.

The consensus rating of Wall Street analysts for ACADIA Pharmaceuticals Inc. is Strong Buy (1.43), with a target price of $25.8, which is +52.30% compared to the current price. The earnings rating for ACADIA Pharmaceuticals Inc. stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

ACADIA Pharmaceuticals Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

ACADIA Pharmaceuticals Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 20.16, ATR14 : 0.65, CCI20 : 58.48, Chaikin Money Flow : 0.05, MACD : -0.39, Money Flow Index : 55.54, ROC : 2.48, RSI : 46.61, STOCH (14,3) : 68.48, STOCH RSI : 0.68, UO : 60.83, Williams %R : -31.52), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of ACADIA Pharmaceuticals Inc. in the last 12-months were: Austin D. Kim (Option Excercise at a value of $153 825), Austin D. Kim (Sold 12 589 shares of value $558 864 ), Elena Ridloff (Option Excercise at a value of $0), Elena Ridloff (Sold 4 099 shares of value $178 975 ), Michael J. Yang (Option Excercise at a value of $0), Michael J. Yang (Sold 2 367 shares of value $112 813 ), Srdjan Stankovic (Option Excercise at a value of $3 034 632), Srdjan Stankovic (Sold 110 461 shares of value $5 882 272 ), Stephen R. Davis (Option Excercise at a value of $0), Stephen R. Davis (Sold 28 489 shares of value $1 189 814 )